These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1080551)

  • 1. Quantal release parameters during fade of endplate potentials.
    Branisteanu DD; Miyamoto MD; Volle RL
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):323-7. PubMed ID: 1080551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and postjunctional neuromuscular blockade by carbachol.
    Volle RL; Henderson EG
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(4):359-70. PubMed ID: 1082104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of physiologic alterations on binomial transmitter release at magnesium-depressed neuromuscular junctions.
    Branisteanu DD; Miyamoto MD; Volle RL
    J Physiol; 1976 Jan; 254(1):19-37. PubMed ID: 175150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of tetraphenylboron on neuromuscular transmission in the frog.
    Marshall IG; Parsons RL
    Br J Pharmacol; 1975 Jul; 54(3):325-32. PubMed ID: 169931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postactivation shifts in the frequency of the miniature potentials of the endplate on stimulation of the motor nerve with rhythms close to the natural].
    Kamenskaia MA; Demekhina KI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1974; 0(8):36-41. PubMed ID: 4425708
    [No Abstract]   [Full Text] [Related]  

  • 7. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity increases quantal size at the frog neuromuscular junction.
    Van der Kloot W; Van der Kloot TE
    Experientia; 1985 Jan; 41(1):47-8. PubMed ID: 3871401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency dependent decrease of quantal content in a drug-treated neuromuscular junction.
    Volle RL
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(3):271-84. PubMed ID: 4354638
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyneuronal innervation and quantal transmitter release in formamide-treated frog sartorius muscles.
    Herrera AA
    J Physiol; 1984 Oct; 355():267-80. PubMed ID: 6149312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium dependence of spontaneous and evoked quantal release at the frog neuromuscular junction.
    Barton SB; Cohen IS; van der Kloot W
    J Physiol; 1983 Apr; 337():735-51. PubMed ID: 6603514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of transmitter turnover at the frog neuromuscular junction estimated by electrophysiological techniques.
    Capek R; Esplin DW; Salehmoghaddam S
    J Neurophysiol; 1971 Sep; 34(5):831-41. PubMed ID: 4328958
    [No Abstract]   [Full Text] [Related]  

  • 13. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD
    J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.
    Wiegand H; Lohmann H; Chandra SV
    Arch Toxicol; 1986 Apr; 58(4):265-70. PubMed ID: 2424403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Binomial parameters of mediator release in the process of facilitation of neuromuscular transmission].
    Zefirov AL
    Neirofiziologiia; 1980; 12(3):314-6. PubMed ID: 6105625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course and magnitude of effects of changes in tonicity on acetylcholine release at frog neuromuscular junction.
    Kita H; van der Kloot W
    J Neurophysiol; 1977 Mar; 40(2):212-24. PubMed ID: 300428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
    Zengel JE; Magleby KL
    J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of etimizol on the neuromuscular synapse of the frog].
    Drabkina TM; Dobretsov MG
    Neirofiziologiia; 1985; 17(6):757-63. PubMed ID: 3003594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.